FDA Regulatory Toolbox for COVID-19 Response;
Research Highlights: Remdesivir,
Hydroxychloroquine/Chloroquine;
Updates from the Front Lines: Florida & India 

FDA Regulatory Toolbox for COVID-19 Response

Elizabeth Sadove, JD

Director of Medical Countermeasures Regulatory Policy,
Office of Counterterrorism and Emerging Threats, Office of Chief Scientist,
Office of the Commissioner, U.S. Food & Drug Administration, Silver Spring, MD                          

Research Highlights: Remdesivir, Hydroxychloroquine & Chloroquine

Charles McKay, MD, FACMT, FACEP

Past President,  American College of Medical Toxicology (ACMT)
Associate Medical Director, CT Poison Control Center
Associate Clinical Professor, University of Connecticut School of Medicine,
Farmington, CT                                                                                                      

Miami Beach, FL

David A. Farcy, MD, FAAEM, FCCM

Chandigarh, India

Ashish Bhalla, MD, FACMT

President, Asia Pacific Association of Medical Toxicology (APAMT);
Professor of Medicine, Medical Toxicologist, Post Graduate Institute of
Medical Education and Research, Chandigarh, India